NASDAQ: BNTC
Benitec Biopharma Inc Stock Ownership - Who owns Benitec Biopharma?

Insider buying vs selling

Have Benitec Biopharma Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Suvretta Capital Management LLCDirector2024-11-203,076$10.22
$31.44kBuy
Suvretta Capital Management LLCDirector2024-11-2024,360$10.22
$248.96kBuy
Suvretta Capital Management LLCDirector2024-11-191,570$9.73
$15.28kBuy
Suvretta Capital Management LLCDirector2024-11-1912,430$9.73
$120.94kBuy
Suvretta Capital Management LLCDirector2024-09-264,605,000$3.86
$17.78MBuy
Suvretta Capital Management LLCDirector2024-09-26588,236$1.93
$1.14MBuy
Suvretta Capital Management LLCDirector2024-09-26576,347$3.86
$2.22MBuy

1 of 1

BNTC insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when BNTC insiders and whales buy or sell their stock.

BNTC Shareholders

What type of owners hold Benitec Biopharma Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Suvretta Capital Management LLC38.03%8,829,053$88.29MInstitution
Suvretta Capital Management LLC5.05%1,171,425$11.71MInsider
Janus Henderson Group PLC3.78%876,523$8.77MInstitution
Adage Capital Partners GP LLC3.62%841,395$8.41MInstitution
Nantahala Capital Management LLC3.61%838,095$8.38MInstitution
Franklin Resources Inc3.43%796,644$7.97MInstitution
Steven Michael Oliveira2.88%668,123$6.68MInsider
Awm Investment Company Inc2.69%625,000$6.25MInstitution
Schonfeld Strategic Advisors LLC1.18%272,817$2.73MInstitution
Vanguard Group Inc0.92%213,067$2.13MInstitution

1 of 3

BNTC vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
BNTC59.07%8.26%Net BuyingNet Buying
DMAC13.05%64.25%Net Buying
LXEO81.33%18.67%Net SellingNet Buying
STRO75.82%18.17%Net SellingNet Selling
PGEN25.76%70.48%Net Buying

Benitec Biopharma Stock Ownership FAQ

Who owns Benitec Biopharma?

Benitec Biopharma (NASDAQ: BNTC) is owned by 59.07% institutional shareholders, 8.26% Benitec Biopharma insiders, and 32.67% retail investors. Suvretta Capital Management LLC is the largest individual Benitec Biopharma shareholder, owning 1.17M shares representing 5.05% of the company. Suvretta Capital Management LLC's Benitec Biopharma shares are currently valued at $11.54M.

If you're new to stock investing, here's how to buy Benitec Biopharma stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.